|
|
40
|
|
|
4331AN
|
|
|
XELJANZ 5MG TAB (PFI/STO) TOFACITINIB
|
|
|
TOFACITINIB
|
|
|
XELJANZ
|
|
|
60'S
|
|
|
C
|
|
|
2,373.42
|
|
|
39.56
|
|
|
5MG
|
|
|
TABLET
|
|
|
0
|
|
|
TAB
|
|
|
PFI
|
|
|
PFIZER CORPORATION
|
|
|
STO
|
|
|
BRYDEN STOKES LTD
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
Oral
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|